Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer-Reference-Cited by-同舟云学术

Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer

Published:2016-06-03 Issue:6 Volume:2 Page:
ISSN:2375-2548
Container-title:Science Advances
language:en
Short-container-title:Sci. Adv.

Author:

Singhal Hari¹,Greene Marianne E.¹^ORCID,Tarulli Gerard²,Zarnke Allison L.¹^ORCID,Bourgo Ryan J.¹,Laine Muriel¹,Chang Ya-Fang¹,Ma Shihong³,Dembo Anna G.¹^ORCID,Raj Ganesh V.³,Hickey Theresa E.²^ORCID,Tilley Wayne D.²,Greene Geoffrey L.¹

Affiliation:

1. Ben May Department for Cancer Research, University of Chicago, Chicago, IL 60637, USA.

2. Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, University of Adelaide, Adelaide, South Australia 5005, Australia.

3. Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75080, USA.

Abstract

Individual and concerted actions of ER and PR highlight the prognostic and therapeutic value of PR in ER + /PR + breast cancers.

Funder

Virginia and D.K. Ludwig Fund for Cancer Research

National Health and Medical Research Council of Australia

National Breast Cancer Foundation

Cancer Prevention and Research Institute of Texas

U.S. Department of Defense

Department of Defense Breast Cancer Research Program

Susan G. Komen Postdoctoral Fellowship

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference51 articles.

1. Estrogen receptors: How do they signal and what are their targets;Heldring N.;Physiol. Rev.,2007

2. Progesterone receptor action: Defining a role in breast cancer;Daniel A. R.;Expert Rev. Endocrinol. Metab.,2011

3. Progesterone signalling in breast cancer: a neglected hormone coming into the limelight

4. The value of estrogen and progesterone receptors in the treatment of breast cancer;Osborne C. K.;Cancer,1980

5. Survival benefit of tamoxifen in estrogen receptor-negative and progesterone receptor-positive low grade breast cancer patients;Yang L.-H.;J. Breast Cancer,2012

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of HDAC6-mediated progesterone receptor expression on the response of breast cancer cells to hormonal therapy;European Journal of Pharmacology;2024-09

2. Antiprogestins for breast cancer treatment: We are almost ready;The Journal of Steroid Biochemistry and Molecular Biology;2024-07

3. Bisphenol-A in Drinking Water Accelerates Mammary Cancerogenesis and Favors an Immunosuppressive Tumor Microenvironment in BALB–neuT Mice;International Journal of Molecular Sciences;2024-06-06

4. PGR-KITLG signaling drives a tumor-mast cell regulatory feedback to modulate apoptosis of breast cancer cells;Cancer Letters;2024-05

5. Molecular Imaging of Steroid Receptors in Breast Cancer;The Cancer Journal;2024-05